USP Pending Monograph Process and USP compliance for Industry

Establishing Impurity Acceptance Criteria as Part of Specs for DMFs Based on Clinical Relevance

ICH Q12: What Industry Needs to Know – Pharmaceutical Quality Symposium 2023

Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies

FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)

Putting the Pieces Together: REMS Logic Model in REMS Design, Implementation, and Evaluation

November 19, 2024 Joint Meeting of the DSaRM and the PDAC

Office of Pharmaceutical Quality (OPQ) Update

77th Cellular, Tissue, and Gene Therapies Advisory Committee

M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms - Implementing the Final Guidance

Advancing Smoking Cessation: FDA and NIH Priorities

Conversations on Cancer - Pediatric Cancers: Navigating the Challenges Together

Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Ca...

USP Salt Policy (December 2014)

National Native American Heritage Month: A Conversation with Dr. Casey Dorr

December 4, 2024 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)

FDA’s New Chapter | FDA In Your Day Ep. 17

FDA Tobacco Rulemaking 101 - How does FDA make rules about tobacco products?

Episode 7 - On The Road with Jim Jones - October 2024

Antibiotics: Know When and How to Use Them

FDA D.I.S.C.O. Burst Edition: FDA approval of Tecelra (afamitresgene autoleucel) for unresectable...